Global Alliance Teams Up with Google

The international Global Alliance for Genomics and Health will be using a programming interface developed by the Internet giant to help its stakeholders analyze genomic data.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ISTOCK, ALENGOThe international collaboration aimed at sharing vast amounts of genetic and clinical information announced last year is gearing up to establish technical, ethical, and legal standards to ensure robust and secure information exchange. The so-called Global Alliance for Genomics and Health, which met earlier this month (March 4) in London, will be using Google Genomics to help its stakeholders analyze genomic data. Google intends to develop a “simple web-based API to import, process, store, and search genomic data at scale,” the company announced last month (February 27) in a post on its Research Blog.

In an interview with Nature, Global Alliance steering committee member David Altshuler of the Broad Institute said that during the last eight months, the group has “gone from a concept to having 151 partners,” including researchers from academic medical centers, information science firms, and disease advocacy organizations, among others.

“Many engaged in the clinical uptake of genomics want better information to help interpret variants for their patients, and most of all . . . they want to maximize the public benefit of genomics,” Altshuler told Nature.

Editor's Note (March 13): This story has been updated to reflect that the Global Alliance will not itself be analyzing genomic data. Rather, the group will be working with partners, including Google, to help its stakeholders do so.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies